The Pharmacokinetics of Long-Acting Antipsychotic Medications

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|9|3|310-317

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.9, Iss.3, 2014-08, pp. : 310-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Antipsychotic Medications

By  

Current Drug Targets, Vol. 13, Iss. 4, 2012-04 ,pp. : 555-560

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

By Samtani Mahesh N.  

Clinical Pharmacokinetics, Vol. 48, Iss. 9, 2009-09 ,pp. : 585-600

Adis International

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H.   Chouinard G.   Margolese H.C.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic Profile and Clinical Efficacy of Long-Acting Risperidone: Potential Benefits of Combining an Atypical Antipsychotic and a New Delivery System

By Ereshefsky Larry  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite

Why State Pharmacy Boards Should Approve the Use of Long–Acting and Nonstimulant Medications for the Management of ADHD

By  

Child and Adolescent Psychopharmacology News, Vol. 13, Iss. 6, 2008-12 ,pp. : 6-7

Guilford Publications Inc

Access to resources Recommend Favorite